These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36060021)

  • 41. Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer.
    Mitsuhashi A; Uehara T; Hanawa S; Shozu M
    Support Care Cancer; 2017 May; 25(5):1495-1501. PubMed ID: 28028620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Endometrial cancer in patients with preoperative diagnosis of atypical endometrial hyperplasia.
    Merisio C; Berretta R; De Ioris A; Pultrone DC; Rolla M; Giordano G; Tateo S; Melpignano M
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):107-11. PubMed ID: 16154046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS).
    Manchanda R; Saridogan E; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Side L; Gessler S; Jacobs I; Menon U
    Arch Gynecol Obstet; 2012 Dec; 286(6):1555-62. PubMed ID: 22865035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
    Minig L; Franchi D; Boveri S; Casadio C; Bocciolone L; Sideri M
    Ann Oncol; 2011 Mar; 22(3):643-649. PubMed ID: 20876910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Analysis of prognosis and pregnancy outcomes of fertility-preserving treatment for patients with stage Ⅰa, grade 2 endometrial cancer].
    Wang YQ; Zhou R; Xu LJ; Xia M; Lu Q; Liu GL; Shen DH; Wang G; He M; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):327-332. PubMed ID: 32464721
    [No Abstract]   [Full Text] [Related]  

  • 46. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
    Pronin SM; Novikova OV; Andreeva JY; Novikova EG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hysteroscopic morphological pattern reflects histological grade of endometrial cancer.
    Miyamoto T; Abiko K; Murakami R; Furutake Y; Baba T; Horie A; Hamanishi J; Mandai M
    J Obstet Gynaecol Res; 2019 Aug; 45(8):1479-1487. PubMed ID: 31074203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.
    Carabineanu A; Zaharia C; Blidisel A; Ilina R; Miclaus C; Ardelean O; Preda M; Mazilu O
    Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684040
    [No Abstract]   [Full Text] [Related]  

  • 49. Correlation between steroid receptor expression and response to progestational therapy in patients with atypical endometrial hyperplasia or cancer.
    Zaiem F; Bedi M; Kheil M; Abujamea A; Jain D; Rosen D; Alkaram W; Kim S; Ali-Fehmi R; Gogoi R
    Gynecol Oncol Rep; 2024 Jun; 53():101402. PubMed ID: 38699462
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Supervised clustering of immunohistochemical markers to distinguish atypical and non-atypical endometrial hyperplasia.
    Laas E; Ballester M; Cortez A; Gonin J; Canlorbe G; Daraï E; Graesslin O
    Gynecol Endocrinol; 2015 Apr; 31(4):282-5. PubMed ID: 25495249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
    Travaglino A; Raffone A; Gencarelli A; Micheli M; Franco L; Zullo F; Mollo A; Di Spiezio Sardo A; Bifulco G; Insabato L
    Int J Gynaecol Obstet; 2022 Sep; 158(3):742-747. PubMed ID: 34837386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of medroxyprogesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer.
    Tamauchi S; Kajiyama H; Utsumi F; Suzuki S; Niimi K; Sakata J; Mizuno M; Shibata K; Kikkawa F
    J Obstet Gynaecol Res; 2018 Jan; 44(1):151-156. PubMed ID: 29121428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
    Bartels PH; Garcia FA; Trimble CL; Kauderer J; Curtin J; Lim PC; Hess LM; Silverberg S; Zaino RJ; Yozwiak M; Bartels HG; Alberts DS
    Gynecol Oncol; 2012 Apr; 125(1):129-35. PubMed ID: 22155796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial.
    Yang BY; Gulinazi Y; Du Y; Ning CC; Cheng YL; Shan WW; Luo XZ; Zhang HW; Zhu Q; Ma FH; Liu J; Sun L; Yu M; Guan J; Chen XJ
    BJOG; 2020 Jun; 127(7):848-857. PubMed ID: 31961463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
    Yamagami W; Susumu N; Makabe T; Sakai K; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
    J Gynecol Oncol; 2018 Mar; 29(2):e21. PubMed ID: 29400014
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atypical endometrial hyperplasia in a 35-year-old woman: A case report and literature review.
    Wu X; Luo J; Wu F; Li N; Tang AQ; Li A; Tang XL; Chen M
    World J Clin Cases; 2021 Nov; 9(31):9629-9634. PubMed ID: 34877300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concurrent endometrial carcinoma in hysterectomy specimens in patients with histopathological diagnosis of endometrial hyperplasia in curettage specimens.
    Dolanbay M; Kutuk MS; Uludag S; Bulut AN; Ozgun MT; Ozcelik B; Serin IS
    Ginekol Pol; 2015 Oct; 86(10):753-8. PubMed ID: 26677585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort.
    Jacobs I; Gentry-Maharaj A; Burnell M; Manchanda R; Singh N; Sharma A; Ryan A; Seif MW; Amso NN; Turner G; Brunell C; Fletcher G; Rangar R; Ford K; Godfrey K; Lopes A; Oram D; Herod J; Williamson K; Scott I; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Skates SJ; Fallowfield L; Parmar M; Campbell S; Menon U
    Lancet Oncol; 2011 Jan; 12(1):38-48. PubMed ID: 21147030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Few-shot learning to identify atypical endometrial hyperplasia and endometrial cancer based on transvaginal ultrasonic images.
    Wang M; Liu W; Gu X; Cui F; Ding J; Zhu Y; Bian J; Liu W; Chen Y; Zhou J
    Heliyon; 2024 Aug; 10(16):e36426. PubMed ID: 39253160
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of clinical data of different endometrial pathological types in perimenopausal women with abnormal uterine bleeding.
    Wang L; Quan S; Bai E; Yang X
    Front Oncol; 2024; 14():1370681. PubMed ID: 38487719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.